The story of Viagra, formerly marketed by copyright, presents a complex case study for backers considering the drug arena . While its groundbreaking success and impact of billions in revenue , the patent lapse has opened the floodgates for competing medications, substantially diminishing earnings opportunities. This change raises concerns about the